Across TCGA pan-cancer cohorts, RNU6-967P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-967P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-967P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-967P expression acts as an unfavorable survival marker.

ACC, UCEC, and KIRC are the cancer types where RNU6-967P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	III,IV	0.145	0.766	<.001	111	view →
UCEC	OS	Tertile	All	0.478	0.876	<.001	108	view →
KIRC	DFS	Tertile	III,IV	0.155	0.747	.001	96	view →
STAD	DFS	Tertile	III,IV	0.148	0.584	.002	63	view →
HNSC	DFS	Tertile	II,III,IV	0.180	0.558	.013	45	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	27	view →
SKCM	DFS	Tertile	All	0.238	0.614	.016	18	view →
TGCT	OS	Tertile	All	0.534	0.968	<.001	18	view →
LAML	DFS	Tertile	All	0.140	0.582	.020	18	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

Exploration

Same gene, other analysis: RNU6-967P tumor-vs-normal RNA expression · all RNU6-967P data types